Dreyfus Andrew 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Dreyfus Andrew
Director
Transactions
- Award
Class A Common Stock
2022-06-01+21,571→ 151,639 total
Footnotes (2)
- [F1]The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year.
- [F2]The total amount of shares beneficially owned has been adjusted to correct prior immaterial computational errors.